Cargando…
Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents
About one-sixth of the world’s population is affected by a neglected tropical disease as defined by the World Health Organization and Center for Disease Control. Parasitic diseases comprise most of the neglected tropical disease list and they are causing enormous amounts of disability, morbidity, mo...
Autores principales: | al Jalali, Valentin, Zeitlinger, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329777/ https://www.ncbi.nlm.nih.gov/pubmed/32100246 http://dx.doi.org/10.1007/s40262-020-00871-5 |
Ejemplares similares
-
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides
por: al Jalali, Valentin, et al.
Publicado: (2018) -
Antiparasitic agents produced by microorganisms
por: Shiomi, Kazuro, et al.
Publicado: (2004) -
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time–Kill Approaches
por: van Os, Wisse, et al.
Publicado: (2021) -
Promising antiparasitic agents from marine sponges
por: Mostafa, Osama, et al.
Publicado: (2022) -
Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
por: Deda, Daiana K., et al.
Publicado: (2020)